These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Beta-adrenergic receptor blocking agents in cardiovascular diseases]. Kedra M Pol Arch Med Wewn; 1971 May; 46(5):525-33. PubMed ID: 4398057 [No Abstract] [Full Text] [Related]
27. Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes. Pierce CW; Johnson BM; Gershon HE; Asofsky R J Exp Med; 1971 Aug; 134(2):395-416. PubMed ID: 4934502 [TBL] [Abstract][Full Text] [Related]
28. Decreased suppressive B cell factor (SBF) in rheumatoid arthritis: evidence for a defect in B cell autoregulation. White RE; Pisko EJ; Foster SL; Panetti M; Turner RA J Immunol; 1986 Mar; 136(6):2151-7. PubMed ID: 3485142 [TBL] [Abstract][Full Text] [Related]
30. The enhancement of the immune response by pain stimulation in mice. I. The enhancement effect on PFC production via sympathetic nervous system in vivo and in vitro. Fujiwara R; Orita K J Immunol; 1987 Jun; 138(11):3699-703. PubMed ID: 3035011 [TBL] [Abstract][Full Text] [Related]
31. Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol. Aarons RD; Molinoff PB J Pharmacol Exp Ther; 1982 May; 221(2):439-43. PubMed ID: 6281414 [TBL] [Abstract][Full Text] [Related]
32. A comparison of the actions of ICI66082 and propranolol on cardiac and peripheral beta-adrenoceptors. Singh BN; Nisbet HE; Harris EA; Whitlock RM Eur J Pharmacol; 1975 Nov; 34(1):75-86. PubMed ID: 11998 [TBL] [Abstract][Full Text] [Related]
33. beta-adrenergic receptor coupled-adenylate cyclase of human fat cell ghosts. Kather H; Vogt B; Simon B Klin Wochenschr; 1977 Jul; 55(13):625-8. PubMed ID: 197299 [TBL] [Abstract][Full Text] [Related]
34. In vitro measurement of the beta-adrenergic blocking properties of ORF 12592, the 5-hydroxy analog of propranolol. Greenslade FC; Newquist KL Arch Int Pharmacodyn Ther; 1978 Jun; 233(2):270-80. PubMed ID: 28704 [TBL] [Abstract][Full Text] [Related]
35. Blockade of cardiac and renal beta-receptors by low dose propranolol in normal subjects. Clues to its antihypertensive effect. Davies R; Pickering TG; Morganti A; Wilson M; Laragh JH Br Heart J; 1979 Mar; 41(3):331-5. PubMed ID: 34409 [No Abstract] [Full Text] [Related]
36. Influence of beta-adrenoceptor blocking agents on lymphocyte function in vitro. Hallengren B; Forsgren A; Melander A Br J Clin Pharmacol; 1982 Apr; 13(4):543-6. PubMed ID: 6121578 [TBL] [Abstract][Full Text] [Related]
37. The properties of beta-adrenoceptor antagonists. Shanks RG Postgrad Med J; 1976; 52 Suppl 4():14-20. PubMed ID: 9628 [TBL] [Abstract][Full Text] [Related]
38. Induction of human rheumatoid factor producing cells by aggregated IgG. Pisko EJ; Turner RA; Foster SL Arthritis Rheum; 1982 Sep; 25(9):1108-16. PubMed ID: 6751337 [No Abstract] [Full Text] [Related]
39. Beta-adrenoceptor antagonists suppress elevation in body temperature and increase in plasma IL-6 in rats exposed to open field. Soszynski D; Kozak W; Conn CA; Rudolph K; Kluger MJ Neuroendocrinology; 1996 May; 63(5):459-67. PubMed ID: 8738584 [TBL] [Abstract][Full Text] [Related]
40. Beta-adrenergic receptors and the effect of beta-adrenergic blocking agent propranolol on histamine and reserpine stimulated gastric acid secretion in man: normals and duodenal ulcer cases. El-Gendi MA; Geumei A; Issa I; El-Shazly MK; Sadek AM Pahlavi Med J; 1976 Jan; 7(1):40-70. PubMed ID: 1264468 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]